Francisca Dias

Scopus Author ID ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Molecules (Basel, Switzerland)

Cancers

Antioxidants (Basel, Switzerland)

International journal of nanomedicine

Instituto Português de Oncologia do Porto Francisco Gentil

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Português de Oncologia do Porto Francisco Gentil Feb 09 2017

Portugal

PhD Grant :: Molecular Oncology & Viral Pathology Group

Liga Portuguesa Contra o Cancro Núcleo Regional do Norte Jan 01 2015

Portugal

Research Fellow :: Research Department

Instituto Portugues de Oncologia do Porto Francisco Gentil Feb 13 2012 - Dec 10 2014

Portugal

Research Trainee :: Molecular Oncology & Viral Pathology Group

Education History

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar Jul 13 2015 - Jul 16 2020

Portugal

PHD

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar Sep 06 2012 - Dec 10 2014

Portugal

MSC

Universidade do Porto Faculdade de Ciências Sep 24 2009 - Sep 08 2012

Portugal

BSC

Publications

Mariana Morais, Francisca Dias, Patrícia Figueiredo, Inês Tavares, Carla Escudeiro, Manuel R Teixeira, Alexandra Teixeira, Johnny Lisboa, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) Uptake by Caveolae-Dependent Endocytosis is Responsible for Their Selective Effect Towards Castration Resistant Prostate Cancer. International journal of nanomedicine 19 (2024)
Beatriz Almeida, Tânia R Dias, Pedro Cruz, Mário Sousa-Pimenta, Ana Luísa Teixeira, Catarina Esteves Pereira, Bruno Costa Silva, Júlio Oliveira, Rui Medeiros, Francisca Dias
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients. Vaccines 12 (8) (2024)
Beatriz Almeida, Tânia R Dias, Ana Luísa Teixeira, Francisca Dias, Rui Medeiros
MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients? Cancers 15 (16) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Mariana Morais, Vera Machado, Patrícia Figueiredo, Francisca Dias, Rogéria Craveiro, Joana Lencart, Carlos Palmeira, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Cristina Almeida, Ana Luísa Teixeira, Francisca Dias, Mariana Morais, Rui Medeiros
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management. Biology 12 (5) (2023)
Mariana Morais, Vera Machado, Patrícia Figueiredo, Francisca Dias, Rogéria Craveiro, Joana Lencart, Carlos Palmeira, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros, Honorina Cidade, Patrícia M A Silva, Fátima Cerqueira
Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions. Molecules (Basel, Switzerland) 28 (5) (2023)
Tânia R Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira, Rui Medeiros
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 11 (15) (2022)
Mariana Morais, Vera Machado, Francisca Dias, Patrícia Figueiredo, Carlos Palmeira, Gabriela Martins, Rui Fernandes, Ana Rita Malheiro, Kirsi S Mikkonen, Ana Luísa Teixeira, Rui Medeiros
Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells. International journal of nanomedicine 17 (2022)
Cristina Almeida, Ana Luísa Teixeira, Francisca Dias, Vera Machado, Mariana Morais, Gabriela Martins, Carlos Palmeira, Maria Emília Sousa, Inês Godinho, Sílvia Batista, Bruno Costa Silva, Rui Medeiros
Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype. Biology 11 (1) (2022)
Mariana Morais, Francisca Dias, Inês Nogueira, Anabela Leão, Nuno Gonçalves, Luís Araújo, Sara Granja, Fátima Baltazar, Ana Luísa Teixeira, Rui Medeiros
Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186. Cancers 13 (7) (2021)
Ana Luísa Teixeira, Ana Sofia Patrão, Francisca Dias, Carlos Silva, Isabel Vieira, José Fernando Silva, Marta Ferreira, António Morais, Joaquina Maurício, Rui Medeiros
AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes. Pharmacogenomics 22 (16) (2021)
Rui Medeiros, Bruno Horta, Joana Freitas-Silva, Jani Silva, Francisca Dias, Maria Emília Sousa, Patrícia M A Silva, Fátima Cerqueira
Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages. Molecules (Basel, Switzerland) 26 (12) (2021)
Francisca Dias, Cristina Almeida, Ana Luísa Teixeira, Mariana Morais, Rui Medeiros
LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression. Biomedicines 9 (2) (2021)
Mariana Morais, Francisca Dias, Ana Luísa Teixeira, Rui Medeiros
Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney. Cancer management and research 12 (2020)
Francisca Dias, Ana Luísa Teixeira, Inês Nogueira, Mariana Morais, Joana Maia, Cristian Bodo, Marta Ferreira, Isabel Vieira, José Silva, João Lobo, José Pedro Sequeira, Joaquina Maurício, Jorge Oliveira, Carlos Palmeira, Gabriela Martins, Klaas Kok, Bruno Costa Silva, Rui Medeiros
Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study. International journal of molecular sciences 21 (13) (2020)
Francisca Dias, Ana Luísa Teixeira, Inês Nogueira, Mariana Morais, Joana Maia, Cristian Bodo, Marta Ferreira, Alexandra Silva, Manuela Vilhena, João Lobo, José Pedro Sequeira, Joaquina Maurício, Jorge Oliveira, Klaas Kok, Bruno Costa Silva, Rui Medeiros
Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease. Cancers 12 (6) (2020)
Fernando V Silva, Francisca Dias, Gustavo Costa, Maria da Graça Campos
Chamomile reveals to be a potent galactogogue: the unexpected effect. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 31 (1) (2017)

Francisca Dias.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francisca Dias